Named on 2 rounds in the feed, most often at Series B.
Rounds from 2025-10-14 to 2026-07-14
ROUNDS
2
joined, none as lead
ROUNDS JOINED · USD
$665M
across 2 rounds
CO-INVESTORS
17
named beside it
Named on 2 rounds in the feed, most often at Series B.
Rounds from 2025-10-14 to 2026-07-14
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Draig A biotech company | Series B Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $65M | 2026-07-14 | [ PART ] |
Kailera Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people living with obesity | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $600M | 2025-10-14 | [ PART ] |